Neuronetics, Inc. held a Special Meeting where stockholders approved several proposals, including increasing authorized shares from 200 million to 250 million and issuing shares to Greenbrook shareholders as part of an acquisition agreement. The proposals received affirmative votes of approximately 69.38%, 67.56%, and 53.56%, respectively.